Topline data were announced from two phase 3 trials evaluating ulixacaltamide in patients with essential tremor.

For patients with focal treatment-resistant epilepsy, seizure frequency improves over time, according to a recent study.

Increasing use of social media throughout early adolescence is associated with lower performance in specific aspects of cognitive function.

A new analysis reveals how deeply the US drug supply chain depends on China and that a trade war could leave American patients at risk.

Phthalate exposure is associated with adverse effects on cardiovascular health in patients with chronic kidney disease.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for CTx-1301 for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adults.

Reduced kidney function from chronic kidney disease may undermine the accuracy of blood-based biomarkers used to predict AD outcomes.

Sex influences how genetic and age-related factors translate into clinical and neuroimaging trajectories in Huntington disease.

From 1990 to 2021, global early-onset PD incidence increased by 286.72%, prevalence by 239.34%, and YLDs by 249.59%. Age-standardized rates also increased, with East Asia, particularly China, ...

The FDA has cleared the Elecsys pTau181 test as an aid in early detection of amyloid pathology in the primary care setting for adults aged 55 years and older presenting with signs, symptoms or ...

Subthalamic deep brain stimulation is an effective long-term therapy for Parkinson disease, according to a recent study.

Women with attention-deficit/hyperactivity disorder face delayed diagnosis and worse outcomes than men, according to a recent study.